ClinicalTrials.gg
Drug

Ensifentrine clinical trials

Also written RPL554.

studies test it
17
open now
1
in phase 3
5
first study started
2014

How each study uses ensifentrine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ensifentrine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Jun 2024 · OHTUVAYRE · NDA 217389 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ensifentrine
6
Ensifentrine 3 mg
2
RPL554 Suspension
2

Development codes

RPL554
6
VMX554
1
VRP554
1
MK-5884
1

Studies by the year they started

17 studies that test it; most in 2017 (3)

Studies that test ensifentrine, by start year
YearStudies
20141
20152
20173
20181
20191
20202
20221
20232
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
10
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 0

Verona Pharma plc (11) · Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA (3) · Nuance Pharma (shanghai) Co., Ltd (2) · Merck Sharp & Dohme LLC (1)

Often tested with

Tested in the same studies.

Glycopyrrolate (2) · Albuterol (1) · Ipratropium (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test ensifentrine.

Studies

Open first, then newest update. How each study uses ensifentrine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

As the comparator · 1 — what is tested is compared with ensifentrine

Codes

What other systems call ensifentrine · ClinicalTrials.gg INT004961

  • MeSH (NLM) C512996ensifentrineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 3E3D8T1GIXENSIFENTRINEConfirmed FDA, NLM, Wikidata
  • Wikidata Q135257708ensifentrineConfirmed FDA, NLM, Wikidata
  • Wikidata Q7277486ensifentrine (stereochemically undefined)Confirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166674EnsifentrineOne source FDA
  • DrugBank DB16157One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.